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Abstract: Forward genetic screens in Drosophila melanogaster using ethyl 
methanesulfonate (EMS) mutagenesis are a powerful approach for identifying genes that 
modulate specific biological processes in an in vivo setting. The mapping of genes that 
contain randomly-induced point mutations has become more efficient in Drosophila thanks 
to the maturation and availability of many types of genetic tools. However, classic 
approaches to gene mapping are relatively slow and ultimately require extensive Sanger 
sequencing of candidate chromosomal loci. With the advent of new high-throughput 
sequencing techniques, it is increasingly efficient to directly re-sequence the whole genome 
of model organisms. This approach, in combination with traditional chromosomal 
mapping, has the potential to greatly simplify and accelerate mutation identification in 
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mutants generated in EMS screens. Here we show that next-generation sequencing (NGS) 
is an accurate and efficient tool for high-throughput sequencing and mutation discovery in 
Drosophila melanogaster. As a test case, mutant strains of Drosophila that exhibited long-
term survival of severed peripheral axons were identified in a forward EMS mutagenesis. 
All mutants were recessive and fell into a single lethal complementation group, which 
suggested that a single gene was responsible for the protective axon degenerative 
phenotype. Whole genome sequencing of these genomes identified the underlying gene 
ect4. To improve the process of genome wide mutation identification, we developed 
Genomes Management Application (GEM.app, https://genomics.med.miami.edu), a 
graphical online user interface to a custom query framework. Using a custom GEM.app 
query, we were able to identify that each mutant carried a unique non-sense mutation in the 
gene ect4 (dSarm), which was recently shown by Osterloh et al. to be essential for the 
activation of axonal degeneration. Our results demonstrate the current advantages and 
limitations of NGS in Drosophila and we introduce GEM.app as a simple yet powerful 
genomics analysis tool for the Drosophila community. At a current cost of <$1,000 per 
genome, NGS should thus become a standard gene discovery tool in EMS induced genetic 
forward screens.  
Keywords: Next-generation sequencing; Drosophila melanogaster; EMS screen 
 
1. Introduction 
Drosophila melanogaster is an extensively studied genetic model organism that has been used for 
the investigation of biological processes common to other organisms, including humans. Over the past 
century, sophisticated genetic approaches have been developed for Drosophila and the use of these 
methods have led to the illumination of fundamental principles in genetics and biology [1].  
The availability of such techniques has made Drosophila one of the most powerful genetic  
model organisms.  
Forward genetic screens theoretically allow for the unbiased and exhaustive identification of sets of 
genes and genetic modifiers responsible for any phenotype of interest [2]. In particular, ethyl 
methanesulfonate (EMS) mutagenesis has been widely used to efficiently induce random point 
mutations. The advantages of EMS are a high rate of mutation, and production primarily of point 
mutations. Such mutations include strong loss of function changes, gain-of-function alleles, and DNA 
variants that result in the alteration of specific protein domains highly informative regarding function. 
However, a major obstacle of EMS-based mutagenesis is the subsequent identification of the causative 
lesions. In most cases, traditional genetic mapping has been used in Drosophila to identify small 
chromosomal loci linked to the phenotype of interest. The majority of these fine-mapping procedures 
are labor, cost, and time intensive. In addition, low recombination rates and insufficient mapping 
stocks hinder the ability to map mutations to some genomic regions. Finally, extensive Sanger 
sequencing of regions of interest are generally required to successfully identify the precise  
causative lesion.  
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The development of next-generation sequencing (NGS) has dramatically improved the throughput 
and cost of sequencing. The size of the Drosophila genome is ~180 million bases (Mb) and is 
predicted to contain 13,601 protein coding genes [3]. The current reference genome dm3 is based on 
the Berkeley Drosophila Genome Project (BDGP) and reliable annotation is available via  
Flybase, ENSEMBL, UCSC Genome Browser and others. Information on common and rare natural  
variation in the Drosophila genome is less well curated, but available from various sources  
(http://flybase.org, http://dpgp.org). Currently, a whole Drosophila genome can be sequenced within a 
few weeks for <$1,000, but this price point will likely drop rapidly in coming years. Not surprisingly, 
a small number of studies have begun to explore the possibility of applying NGS to EMS-induced gene 
identification. These studies have shown in principle that a known mutation can be re-identified [4], 
and that sequence capture/enrichment of regions of interest will also allow for reliable mutation 
detection [5]. Albeit the technical challenges of NGS appear largely resolved, user-friendly 
bioinformatics analysis tools designed for the wet lab based molecular-oriented Drosophila scientist 
are still warranted. Each Drosophila genome represents a large amount of data and can thus be 
challenging to analyze. However, the main routes of analysis for the purpose of gene mapping can be 
summarized in a standardized bioinformatics pipeline. Here we present a novel genomes management 
tool with a graphical user interface that is accessible through any major web browser. In order to 
demonstrate the effectiveness of NGS in the identification of causative mutations, we present detailed 
data from a recent discovery of the first natural gene required for Wallerian degeneration [6].  
2. Methods 
2.1. Sample Preparation 
For DNA preparation, 200 anesthetized flies were flash frozen on dry ice then homogenized in  
300 ?L of sterile-filtered Buffer A (10 mM Tris-Hcl, pH7.5; 60 mM NaCl; 10 mM EDTA; 150 nM 
spermine; 150 nM spermidine; 5% sucrose; 0.5% Triton-X). After centrifuging at 4C at 15,000 RPM 
for 15 minutes, the supernatant was discarded and the nuclei (pasty layer of the pellet) was carefully 
resuspended in 300 ?L l Buffer A. The resuspended nuclei were transferred to a tube containing  
300 ?L of sterile-filtered Buffer B (2% N-lauryl sarcosine; 0.1M EDTA; 5% sucrose) and heated to  
65 °C for 45 minutes. 800 ?L of 1:1 phenol:chloroform mix (Fisher Scientific) was added to the 
mixture followed by vortexing for 10 seconds. After a 10 second rest, the mixture was vortexed again 
for 10 seconds and then spun at 15,000 RPM for 5 minutes at room temperature. The supernatant was 
removed and mixed with 600 ?L chloroform. The mixture was vortexed and spun as before. The 
supernatant was removed and an equal volume of isopropanol was added. After several inversions, the 
mixture was spun at 4 °C at 15,000 RPM for 15 minutes. The pellet was then washed with 500 ?L of 
70% ethanol and spun at 4 °C at 15,000 RPM for 5minutes. The supernatant was removed and the 
pellet was allowed to air dry before resuspension in TE2 with RNAse (10 mM Tris-Hcl, pH7?8; 2mM 
EDTA; 10 ug RNAse A). The mixture was incubated at 37 °C for 30 minutes. The DNA was 
reprecipitated with 200 ?L 100% ethanol and then spun at 15,000 rpm for 15 minutes at 4 °C. The 
pellet was washed and resuspened as before with 70% ethanol. After air drying, the pellet was 
resuspended in TE2 (without RNAse). All chemicals are from Sigma unless otherwise noted. 
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2.2. Illumina Whole-genome Sequencing 
??????????????????????????????????????????????????????????????????????????????????????????
Sample Preparation protocol, including a gel-based size-selection such that final median insert size 
was 300 bp. Samples were barcoded to allow for multiplexing. Cluster generation took place on the 
Illumina cBot according to the manufacturer's recommendations. Sequencing was performed on the 
Illumina HiSeq2000 using the reagents provided in the Illumina TruSeq PE Cluster Kit v3 and the 
TruSeq SBS Kit ? HS (200 cycle) kit.  
2.3. Data Analysis and Variant Detection 
The Illumina CASAVA v1.4 and v1.5 pipeline was used to produce 74bp sequence reads.  
BWA [14] was used to align sequence reads to the Drosophila melanogaster reference genome (dm3) 
and variants were called using the GATK software package v1.4 [11]. All variants were submitted to 
ENSEMBL Variant Effect Predictor for further characterization. Genomes Management Application 
(GEM.app), University of Miami Miller School of Medicine (https://genomics.med.miami.edu) was 
utilized for analysis of variants detected. In order to reduce the number of false positive genotype calls, 
????????????????????????????????????????????????????????????????????????????????????????????????????
genotype quality score (GQ) is a Phred-scaled likelihood confidence score that the genotype of a 
variant is correct. For heterozygous variations, the GQ equation is as follows: 
?? ? ???????????????
???????????????????????????????????????????????????????????????
? with a max score of 99. The 
QUAL score is the Phred probability that a variant polymorphism exists at a given site given the 
sequencing data, where a score of 10 indicates a 1 in 10 chance of error and a score of 100 indicates a 
1 in 100 chance of error. 
3. Results 
3.1. Whole Genome Sequencing Analysis of D. melanogaster 
The Illumina HiSeq2000 sequencing platform was used to generate whole genome data sets on four 
Drosophila samples, a background strain (y,w) and three mutant strains (mut1, mut2, mut3). The 
mutant strains were identified in an EMS mutagenesis as capable of blocking axonal degeneration after 
axotomy. Each of these lines were homozygous lethal and we therefore performed whole genome 
sequencing on heterozygous animals crossed over the original background chromosome (e.g., y,w ; 
mut1/+). The sequence data corresponded to an average of ~74 million 74bp sequence reads per 
sample (control: 42,278,410; mut1: 83,425,870; mut2: 43,972,798; mut3: 125,284,692). Applying 
standard sequence read alignment software (BWA), 88% of paired-end reads were aligned to the 
Drosophila reference sequence (dm3) (Table 1). The resulting average sequence read depth per sample 
was 41X across the genome (Table 1). This coverage depth has been shown previously to be sufficient 
for the identification of heterozygous mutations [7]. EMS mutagenesis is known to induce point 
mutations by nucleotide substitution, particularly by guanine alkylation [8]. Therefore we limited our 
analysis to single nucleotide variations (SNVs). We also explored the efficiency of filtering for G/C to 
A/T transitions as 70%?100% of EMS induced mutations have been reported to fall in this  
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category [9,10]. By applying the GATK software, we detected a total of 2,155,300 SNVs in three 
mutant strains, an average of ~718,000 variations per mutant genome (Table 1). Since many of the 
variant calls have very low quality or low sequence coverage we applied conservative quality filters. A 
GQ score of ? 75 and QUAL score ????? ????????????????????????????????????????????????????????????
this site and 107.5 likelihood that the genotype call is correct [11]. Application of these quality filters 
reduced the number of SNVs to ~390,000 per mutant, which were then considered for subsequent 
analyses (Table 1).  
Table 1. Whole genome sequencing metrics per sample. 
Sample # of reads 




















cSNV on 3L 
Background 42,278,410 37,650,186 88.1 27.1 412,362 88,593 21,745 2,851 25 
Mutant 1 83,425,870 72,784,178 87.2 44.6 849,658 456,778 35,172 6,544 863 
Mutant 2 43,972,798 38,172,143 86.81 23.4 647,655 427,332 25,054 5,252 533 
Mutant 3 125,284,692 111,178,422 88.7 68.1 657,987 231,449 32,114 4,913 48 
Total in 
Mutants 
    2,155,300 1,115,559 92,340 16,709 1,444 
# - number; SNV ? single nucleotide variant; cSNV ? coding SNV; NS/SS ? nonsynonymous/splice site; 3L ? 
chromosome 3L. 
To obtain a better understanding of the frequency of natural DNA variation and EMS induced 
mutations, we analyzed the distribution of SNVs per chromosome. The larger autosomes and the X 
chromosome contained between ~8,100 to ~11,000 homozygous and heterozygous variants per 
megabase (Mbp) of DNA sequence (Table 2). Chromosome 4 and YHet displayed less variant density 
(Figure 1). Approximately 3% of SNVs not shared between any mutant and background genomes were 
non-synonymous or splice-site variations (Figure 1). Of those, 52% represented G->A or C->T 
changes, in line with the EMS induced guanine alkylation. This number is at the lower end of previous 
observations [9,10], but is likely explained by us only analyzing one parental genome. Overall we 
observed a mutation rate of ~0.6 mutations per 1kb, which coincides with previous reports [5].  
Table 2. Observed number of SNVs per million base pair (Mbp) in each chromosome. 
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Figure 1. Distribution of detected SNVs not present in background on each chromosome. 
Purple bars represent the total number of SNVs that were observed in mutant genomes but 
not in the background genome. Green bars represent the number of SNVs that were G>A 
or C>T transitions. Red bars represent the number of nonsynonymous or splice-site SNVs 
that were not present in the wild-type genome and detected in the mutant genomes. Blue 
bars represent the number of nonsynonymous and splice-site SNVs that were G>A or C>T 
transitions.  
 
3.2. Gene Identification Applying WGS 
We sequenced genomic DNA from a background strain and three heterozygous non-complementing 
mutants. The phenotype of these mutants was delayed axonal degeneration upon nerve severance and 
the responsible gene and its biology was recently published [6]. Beginning with the entire number of 
homozygous and heterozygous changes in each of the four genomes, we devised a step-wise filtering 
approach that would reduce the number of SNVs in each individual mutant strain. Cross-comparisons 
between the non-complementing strains would then possibly identify the underlying gene. Firstly, we 
limited analysis to the ~10,000 genes per mutant strain that contained a coding variant (Figure 2). 
When only considering heterozygous non-synonymous and splice-site changes the number of genes 
was reduced by ~40%. Further, the variant should not be present in the background strain (reduction to 
~4,000 genes) and should be an EMS induced G>A or C>T transition (reduction to ~2,900 genes) 
(Figure 2). Next, we used phylogenetic analysis based conservation scores (PhastCons) of 15 fly 
species available on the UCSC genome browser (http://genome.ucsc.edu/). PhastCons predictions are 
based on a phylogenetic hidden Markov model to identify conserved elements in multiple aligned 
sequences [12]. Using these scores, we filtered for moderately conserved variants (PhastCons > 0.5) 
further reducing the number to 1161 candidate genes (Figure 2). In addition, it is unlikely that the same 
mutation will occur in eight other Drosophila genomes that we have sequenced for other unrelated 
projects (reduction to 139 genes across the whole genome). Finally, since the initial screen was 
performed on chromosome 3L, we were able to reduce the number of candidate genes to 18 (Figure 2).  
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Figure 2. Filtering strategies used for gene identification by whole genome sequencing. 
Each box lists the number of genes with one or more protein-coding SNV (cSNV). 
Columns show the effect of requiring that one or more cSNV be observed in each of one to 
three mutant flies. Rows show the effect of filtering variants that meet certain analysis 
criteria. Row 6 displays the effect of including 8 samples from different screens  
in analysis.  
 
The power to detect the underlying gene dramatically increases if multiple non-complementing 
strains are available suggesting that each strain has a unique mutation in the same gene. When 
combining the data from two such strains the number of possible genes in the whole genome is 
reduced to four and only one gene, ect4, contained significant unique changes in each mutant strain on 
chromosome 3L (Figure 2). As expected, by adding a third non-complementing strain, ect4 can be 
directly identified genome wide (Figures 2 and 3). 
Figure 3. Mutation density on chromosome 3L in screen (N = 3). (A) Screenshot of 
chromosome 3L with custom tracks in the UCSC genome browser. The pink line displays 
all SNVs on chromosome 3L that were detected in this screen. The navy line displays all 
heterozygous non-synonymous and splice-site SNVs on chromosome 3L not present in the 
wild-type fly. (B) Screen shot of ect4/dSarm with custom track displaying the location and 
conservation of the three ect4 mutations.  
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The proposed filtering strategy will differ depending on investigator opinions for appropriate cut-
offs for conservation, the order of filter options, the availability of non-complementing mutant strains, 
and the extent of available genetic mapping data. Ideally, a software application will allow for a rapid 
and iterative trial and error approach towards optimizing the filtering strategy for each screen and 
dataset. We have therefore developed a user-friendly web-based tool, which can be tailored to fit the 
needs of individual projects and users to analyze and compare entire Drosophila genomes  
within seconds. 
3.3. The Genomes Management Application (GEM.app)?A Novel Tool for Rapid Genome Analysis 
and Comparison 
In order to facilitate the storage, annotation, analysis, and visualization of NGS variant data, we 
have developed Genomes Management Application (GEM.app, https://genomics.med.miami.edu), an 
online graphical interface to a custom query framework. GEM.app imports data from a standardized 
and automated variant calling pipeline; in our case a BWA/GATK pipeline that produces files in the 
variant call format (VCF) (see methods for details). The genome data import module (GEDI) of 
GEM.app handles the annotation of all variants, the calculation of frequency counts across samples in 
a central database, and also determines for each variant if the original VCF files contain the reference 
allele or reports missing data (???????????????(Figure 4a). A graphical user interface eliminates the need 
for command line or bioinformatics knowledge (Figure 4b). For data queries, GEM.app is accessed in 
a standard web browser and allows for the selection of multiple filters, which largely replicate the 
analytical strategy described above. Specifically, the user can filter for variant function class 
(synonymous, nonsynonymous, nonsense, etc.), zygosity (homozygous, heterozygous, hemizygous), 
allele frequency of variants across the entire database, conservation scores, chromosomal regions and 
genes of interest, and guanine alkylation derived changes. Most importantly, analysis across samples in 
a project is possible and allows utilizing the power of multiple non-complementing strains. After 
submission of query criteria, output is displayed in the web browser, which includes features such as 
direct links to ENSEMBL gene viewer, a gene network viewer [13], and the optional download of 
results in a tab-delimited format that directly opens in Excel (Figure 4c). Benchmarking of query times 
revealed an average of 0.15 seconds for a single whole Drosophila genome. Queries across four whole 
genomes as presented in this paper averaged 0.27 seconds.  
In addition to being user-friendly and fast, GEM.app is a centralized data storage system for many 
studies. GEM.app is password protected and each user has restricted rights only to their own genome 
data. It is very convenient for a single laboratory and its multiple lab members to access genomic data 
from any computer or mobile device. In addition, every new sample that is added improves the 
knowledge on variant frequencies in the Drosophila genome and these frequencies are available to all 
users in an anonymous count. For example, when we added the genomic information from eight 
additional EMS-induced Drosophila genomes not related to the presented study, we were able to 
reduce the number of remaining genes by ~90% (Figure 2).  
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Figure 4. GEM.app bioinformatics pipeline and online graphical interface. (A) The 
systematic processes of the automated GEM.app bioinformatics pipeline. (B) Screenshot of 
the GEM.app form with some of the filtering options displayed. (C) The output of 
GEM.app query used to identify ect4 mutations. A subset of 34 total columns are shown. 
Links within the table (U, N, S, e) provide direct access to common resources, such as 
UCSC genome browser, NCBI, String gene networks, and Ensembl. Up to three tabs allow 
for parallel queries. Additional options include modifying filter settings, managing 





Before the advent of whole genome sequencing, fine mapping techniques were used to identify 
mutations involved in phenotypes of interest in genetic screens followed by Sanger sequencing. This 
approach has been very successful, but can be time-consuming and expensive. Sequencing and 
analysis of the whole Drosophila genome now takes 2-3 weeks and costs <$1,000, making NGS an 
increasingly inexpensive and potentially high-throughput experiment. In our experience, a full 
Illumina HiSeq2000 run could produce 64 high-quality Drosophila genomes. Further price reductions 
will likely stimulate large-scale EMS screens, because it allows for an unbiased search for mutants 
across whole genomes. The biggest conceived obstacle to a wider adoption of this approach is 
arguably the bioinformatic challenges posed by whole genome analysis. More specifically, the user-
friendly accessibility of genome data to the molecular-genetic-oriented investigator is essential for the 
widespread implementation of these techniques.  
Our results demonstrate that whole genome sequencing is an effective method to identify  
EMS-induced variants in a novel gene underlying a Drosophila model for delayed Wallerian 
degeneration [6]). This is in line with other studies that have applied targeted NGS and whole genome 
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sequencing to Drosophila [4,7]. We showed that a number of experimental and analytical strategies  
are viable: 
1. If a single mutant line exists, the parallel sequencing of the background strain and mapping to a 
chromosomal arm will reduce the number of genes carrying a strong coding variant to less than 
20, possibly even identifying a strong mutation outright. 
2. It is most advantageous to add a second non-complementing strain to filter for genes that 
contain strong variants in both strains. In this case, further mapping of the gene is not even 
necessary in most cases (Figure 2). 
3. Adding more Drosophila genomes, related or unrelated to a project, has a great potential to 
further eliminate variants with a low frequency in the Drosophila population; or alternatively, 
nucleotide positions that are frequently hit by the EMS mutagen.   
In our opinion, this approach can be further improved by utilizing evolutionary conservation scores 
and, in the future, by adding comprehensive in silico predictions for protein changes as they exist in 
human genetic maps.  
It is important to mention, that this approach has some potential shortcomings, which will not 
always lead to straight forward mutation identification. First, we have focused analysis on coding 
variation. If the underlying mutation is in non-coding, intronic, or intergenic regions the number of 
potential variants is much larger. This could, however, be addressed by positional fine mapping. 
Second, repetitive or homologous regions of genomes are notoriously difficult to cover with short-read 
sequences that are produced by the major NGS platforms. Finally, current bioinformatics techniques 
and NGS sequencing protocols require specialized approaches to detect large chromosomal structural 
variations, large insertions/deletions, or copy-number variations. GEM.app does not currently provide 
these analyses. 
Analyzing and visualizing variant data can be extremely daunting to investigators with limited 
computational experience. In order to address the bioinformatics challenge we are presenting the 
Genomes Management Application (GEM.app). The framework of GEM.app has been developed for 
human, mouse, and fly genomic data, but we will describe the human and mouse versions in separate 
papers. GEM.app provides a graphical online user interface, allowing users of varying computational 
skills to analyze NGS data. Little to no prior experience is required to filter existing data and download 
the results to a local computer. In addition, GEM.app is an application that allows for centralized data 
storage, annotation, and analysis. An advantage of this approach is the accumulation of variant 
frequencies across different projects and users. Each user has a unique account with access to their 
data only. However, anonymous variant frequency counts are available to all users across GEM.app. 
The currently available queries are designed to meet most needs for the filtering of EMS-induced 
variants in single strains or across non-complementing strains. A great advantage of GEM.app is the 
speed of analysis, which enables a bioinformatics naïve investigator to test different filter strategies or 
varying cut-offs exhaustively and obtain immediate feedback. The identification of ect4 as described 
above is now literally achieved in seconds.  
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5. Conclusions 
Connecting the efficiency of EMS mutagenesis with the high-throughput capabilities of NGS and a 
powerful yet simple analysis approach will undoubtedly speed up the characterization of genes. As the 
number of available Drosophila genomes increases, we will rapidly refine our understanding of the 
effect of EMS mutations on gene and protein function and the roles they play in mutant phenotypes. 
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